PetCaseFinder

Peer-reviewed veterinary case report

Early blood and urine protein changes in Abyssinian cats

By Paltrinieri, S et al.·Published in Journal of veterinary internal medicine·2015·Department of Veterinary Sciences and Public Health, Italy·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Changes in serum and urine SAA concentrations and qualitative and quantitative proteinuria in Abyssinian cats with familial amyloidosis: a five-year longitudinal study (2009-2014).

Species:
cat

Plain-English summary

A group of 23 Abyssinian cats was monitored over five years to study familial amyloidosis, a condition that can lead to serious health issues. While no cases were found in one cattery, 7 out of 14 cats from another cattery developed the disease. Researchers found that while serum amyloid A levels didn't help in identifying affected cats, increased levels of urinary SAA were noted, especially in the later stages of the disease. This suggests that monitoring urinary SAA could help catch familial amyloidosis earlier, even before symptoms appear.

People also search for: Abyssinian cat kidney disease · cat protein in urine · familial amyloidosis in cats · early signs of kidney disease in cats

Abstract

BACKGROUND: Diagnosis of familial amyloidosis (FA) in Abyssinian cats usually is made on postmortem examination. HYPOTHESIS/OBJECTIVES: Sequential analysis of serum SAA (sSAA), urinary SAA (uSAA), urinary protein:creatinine (UPC) ratio, or sodium-dodecylsulfate agarose gel electrophoresis (SDS-AGE) may facilitate early identification of cats with FA. ANIMALS: Twenty-three Abyssinian cats belonging to cattery A or B (low and high prevalence of FA, respectively). METHODS: Prospective longitudinal study using 109 blood and 100 urine samples collected over 4-year period every 4 months, if possible, or more frequently in case of illness. Cats that died during study were necropsied. Health status of live cats was checked 5 years after enrollment. Serum amyloid A (sSAA) and urinary SAA (uSAA) were measured using ELISA kit. The UPC ratio and SDS-AGE also was performed. RESULTS: Familial amyloidosis was not identified in cattery A, whereas 7/14 cats from cattery B had FA. Serum amyloid A concentrations were not significantly different between cats in catteries A and B or between cats with or without FA, despite frequent peaks in cats from cattery B. Conversely, uSAA was significantly higher in cattery B, especially in the terminal phases of FA. Proteinuria occasionally was found in cats from both catteries, especially in those with FA. Urine protein electrophoresis identified mixed proteinuria only in cats with FA. CONCLUSIONS AND CLINICAL IMPORTANCE: Serum amyloid A and UPC ratio are not helpful for early identification of Abyssinian cats with FA. Conversely, increases in uSAA with or without mixed proteinuria may be found before onset of clinical signs in cats with FA.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/25776129/